Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …

The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …

[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

Positron-Emission Tomography and Assessment of Cancer Therapy | New England Journal of
Medicine Skip to main content Access provided byTE WHATU ORA HEALTH NEW ZEALAND …

Positron emission tomography (PET) is the most powerful molecular imaging technique
currently available for clinical use. Because deranged tumour metabolism is a common …

Positron emission tomography (PET) is now an important cancer imaging tool, both for
diagnosis and staging, as well as offering prognostic information based on response. This …

Cancer cells show increased metabolism of both glucose and amino acids, which can be
monitored with 18 F-2-deoxy-2-fluoro-d-glucose (FDG), a glucose analogue, and 11 Cl …

Radiation therapy is one of the cornerstones for the treatment of thoracic malignancies.
Although advances in radiation therapy technology have improved the delivery of radiation …